TDCH 30DC Inc (PK)

Item 1. Reports to Stockholders.

The Report to Shareholders is attached herewith.

KALMAR POOLED INVESTMENT TRUST

Kalmar “Growth-with-Value” Small Cap Fund

Annual Report

December 31, 2013

This report has been prepared for the general information of Kalmar Pooled Investment Trust shareholders. It is not authorized for distribution to prospective investors unless accompanied or preceded by a current prospectus. Investors are reminded to read the prospectus carefully before investing or sending money.

KALMAR

POOLED

INVESTMENT

TRUST

“GROWTH-WITH-VALUE”

SMALL CAP FUND

Report from Management

December 31, 2013

January 30, 2014

Dear Fellow Shareholders and Friends:

In the lexicon of the past few years, 2013 was certainly a “risk-on” year for U.S. equity investors overall and particularly for smaller company investors. The Russell 2000 Index had its fourth best year ever, with the Growth subset of the Index performing 4.5% better, ending the year up 43.3%. Despite a Fourth Quarter that saw the small stock indexes advance powerfully, investors mixed a little caution into the otherwise “pedal to the metal” behavior that was most rewarded in the market last year. Accordingly, the S&P 500 outperformed them quarterly for the first time in 2013. Also, while the three smallest market cap quintiles within the Russell 2000 Growth Index outperformed notably again and stocks with prices under $5 were far stronger than those with higher prices, at the same time – in a seemingly tentative shift from earlier in the year – investors favored companies in the highest ROE quintiles, companies with lower rather than high-to-infinite P/E’s, and companies with lower expected growth rates. These Fourth Quarter performance influences represented a mixed environment for Kalmar’s investment style, yet good stock picking helped us outperform for December and the full Fourth Quarter in the Kalmar “Growth-with-Value” Small Cap Fund.

Note: Returns shown longer than 1-year are annualized. The performance data quoted represents past performance. Past performance does not guarantee future results. Investment return and principal values will fluctuate, and upon redemption shares may be worth more or less than original cost. The Fund’s current performance may be lower or higher than the performance data quoted. Contact the investment adviser at 800-463-6670 to obtain performance current to the most recent month-end. The table does not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares. The Fund’s annual gross operating expenses for the Investor, Advisor and Institutional classes, as stated in the current prospectus, are 1.52%, 1.37% and 1.27%, respectively. This rate can fluctuate and may differ from that printed in the prospectus. As of December 31, 2013, the expense ratios were 1.29%, 1.32% and 1.22% respectively. The Fund imposes a 2.0% redemption fee on shares redeemed within 90 days of purchase. Small company stocks are generally riskier than large company stocks due to greater volatility and less liquidity. You cannot invest directly in an index. ^a Investor class performance prior to May 1, 2013 reflects certain sub-accounting and shareholder

1

KALMAR

POOLED

INVESTMENT

TRUST

“GROWTH-WITH-VALUE”

SMALL CAP FUND

Report from Management — continued

services fees similar to the formal Shareholder Services Fees plan initiated on that date and deducted from the Fund’s assets at the annualized rate of 0.25%. ^b Advisor Class federal registration was effective beginning April 22, 2013 but the class did not begin operations until July 18, 2013. Advisor Class performance prior to July 19, 2013 is the performance of the Investor Class. ^c Institutional Class federal registration was effective beginning April 22, 2013 but the class did not begin operations until May 14, 2013. Institutional Class performance prior to May 15, 2013 is the performance of the Investor Class.

It is our full year 2013 performance, however, that most gratifies us on behalf of shareholders. The principal reason is that, despite the slight shift at year-end, for the full year low market cap and low quality performance factors clearly dominated returns among smaller companies. Driving performance conspicuously for the year were the very smallest market caps, the non-earners, the lowest-ROE’s, the higher-Beta’s, and the highest-debt-to-cap stocks. This had the biggest negative impact on our comparative performance in the First Quarter when the Kalmar Fund lagged our primary benchmark, the Russell 2000 Growth, by approximately 3.0% percentage points. Critically, Kalmar maintained conviction in our company research and our commitment to high quality business ownership, to inefficient valuations which we judged could rise, and to employing strong risk control in all aspects of the investment process. Despite the persistence of the low quality trends throughout the following nine months, we gradually pulled back to effectively even with the Fund’s powerful benchmark, while importantly taking less risk. Witness the fact that this fine performance for the year came despite a very large underweight to the highest performing sector in the Index, namely Health Care, because for sensible risk control reasons we elect to avoid the volatility, binary risk, cash burn, and money-losing character of the many small speculative Pharma and Biotech stocks that comprise half that sector in the Russell 2000. (You’ve heard this litany from Kalmar many times before.) We believe a good job for the year 2013, thanks to the collective capabilities of Kalmar’s experienced team and the fundamental productivity of our “Growth-with-Value” investment philosophy.

Fourth Quarter Performance Attribution (Please recall that Kalmar invests bottom-up, not top-down sectorally.)

Evaluating the Fourth Quarter in general, our longer term “stock selection” was the prime driver of good returns, as it was all year. That positive effect was partially offset by a slightly rising cash position that came about as we rigorously employed our “peel the onion” strategy to pare back positions as short term price targets were met and market valuations continued to expand. Though our pipeline of new ideas is fertile, we were temporarily a bit cautious redeploying cash as we either trimmed or sold holdings outright.

Looking at performance attribution specifically, our holdings in the Technology sector – our largest sectoral allocation – contributed the most and were up approximately double the overall sector. Our holdings in the Materials & Processing, Financial Services, Health Care, and Consumer Staples sectors also contributed to relative returns. It is interesting to note that this quarter within Health Care the Biotech industry was essentially flat while the Pharma industry was strong and outperformed both the sector and the overall benchmark. In past periods these two industries have moved approximately in tandem with each other. Our Health Care results contributed this quarter because we enjoyed good results from most of our holdings there and our single holdings from both the

2

KALMAR

POOLED

INVESTMENT

TRUST

“GROWTH-WITH-VALUE”

SMALL CAP FUND

Report from Management — continued

Biotech and Pharma industries outperformed nicely. Offsetting these contributions was relative underperformance among our holdings in the Consumer Discretionary and Energy sectors. Aside from the more meaningful impact of cash mentioned above, our sector weighting differentials made little difference to relative return individually or in aggregate.

Recent Portfolio Activity ¹

During the Fourth Quarter we purchased 3 new holdings for the Kalmar Fund (and sold 13 completely) “Peel the Onion” trim and “Beef Up” decisions were active in our effort to optimize future portfolio reward-to-risk and, as mentioned, to control risk. Examples of recent new purchases include:

Portfolio Positioning

Kalmar invests with a forward horizon of at least one to several years, seeking strong returns with lower risk over longer time frames. We don’t attempt to trade short term themes and sector shifts. Our research is intensely bottom-up focused

3

KALMAR

POOLED

INVESTMENT

TRUST

“GROWTH-WITH-VALUE”

SMALL CAP FUND

Report from Management — continued

on developing proprietary conviction in a company’s fundamental ability to deliver above-expectation competitive gains, revenue growth, margin expansion, earnings progress, and cash generation. Accordingly, our sector weights evolve slowly and organically over market cycles.

That said, our bottom-up research has led the Kalmar Fund to be overweight in the Materials & Processing, Producer Durables, and Technology sectors. These sectors of the economy offer many opportunities to qualify growth companies with special attributes such as intellectual property, niche expertise, or manufacturing/service dominance, to name a few, that can be leveraged across the globe rather than just in the U.S., which can give them larger addressable markets and longer runway for potential growth. Though more economically sensitive, such companies can have relatively fewer competitors, which enhances pricing power, while their regulatory oversight can be less onerous than in other industries. Further, unlike many growth stocks now, certain of these companies trade at moderate multiples of 2014 and 2015 consensus earnings expectations. This should make for attractive reward-to-risk opportunities, particularly when our research can develop a differentiated earnings power assessment for the particular business. And if we are indeed on the cusp of improving world growth, this could also provide a helpful tailwind for such companies.

In contrast, we remain underweight in the Health Care and Financial Services sectors. The Health Care underweight results mostly from our oft-described risk control discipline to avoid the “binary risk” and other higher risk/lower reward characteristics of many smaller limited-product Pharmaceutical and Biotech companies, such as speculative valuations, negative earnings, and cash burn. Moreover, policy uncertainty related to “Obamacare” as it will impact Health Care services and reimbursement rates makes it that much more difficult to find companies able to lower costs, improve patient outcomes, and grow unimpeded. We think better opportunities can be found elsewhere. The same is true of the now more highly regulated Financial Services sector, where we have been systematically underweight for years. This is because most garden-variety banks, insurers, finance companies, and REITs either broadly do not meet our growth investment criteria or have unacceptable “transparency risk” related to the quality of their assets when they attempt to grow rapidly. For graphic examples, just think back to the Financial Crisis.

While purposefully avoiding direct investment in smaller Biotechs, or Banks with outsized growth ambitions, or other volatile groups like commodity-dependent companies, Kalmar invests in such industries indirectly by identifying service companies supplying their particular needs, or the needs of their customers, without taking on the sorts of risks referred to above. Related to Biotech binary risk for instance, think of the good growth companies that developed selling picks and shovels to the miners during the gold rush, rather than the difficulty of attempting to divine in advance the scarce few in the gold camps that would ever actually strike paydirt.

That said, Biotechs in the Russell 2000 index comprise such a large 7% weighting that it is nearly impossible to create adequate indirect exposure when such a group is on fire like recently. The good news is that such periods have generally been short-lived and self-correcting, though this one is proving longer-lived, primarily because of takeovers by Big Pharma seeking to boost their drug pipelines. Still, in the interest of better risk control, if we can’t

4

KALMAR

POOLED

INVESTMENT

TRUST

“GROWTH-WITH-VALUE”

SMALL CAP FUND

Report from Management — continued

create indirect angle shots, then we accept the consequences when some group that doesn’t meet our rigorous investment criteria fires up. Whatever the momentary outcome, over time this particular risk-avoidance practice has proven to be beneficial to longer term portfolio returns while also damping volatility. Moreover, good fundamental stock picking in systematically underweighted groups can deliver significant relative contribution vis-à-vis the indexes. Witness the big impact our few differentiated Financial Service holdings had in the Fund portfolio for the Year 2013.

Reasonable valuation is a critical concept of course. Much of 2013’s strong equity returns came from rising stock valuations in certain areas, plus an expanding market multiple generally, rather than commensurately strong corporate earnings growth. Ballooning valuation was most notable in several areas, some not especially healthy. Examples include: many Micro-Caps; low quality/non-earnings companies; Biotechs; some Consumer Staples names; social media stocks, IPO’s and the like; as well as purportedly bullet-proof ultra high revenue growth companies with little earnings. Performance/momentum chasing accounted for much of this. So, how in such an environment does Kalmar cope with this performance influence, attempt to protect against excesses, and create future opportunities?

First, Kalmar is avoiding what appear to be extremes by maintaining our quality and valuation disciplines – yet nevertheless has succeeded in running neck and neck with the exceptionally strong yet low-quality-driven Russell 2000 Growth index return for the year 2013, importantly with less risk taken. Second, we are carefully adhering to our “Peel the Onion” strategy that seeks to successfully harvest partial positions in winning stocks when they exceed our short term price targets. The intended benefits of this are to maintain a reasonable valuation for the overall portfolio, guard against unforeseen company mis-steps or competitive threats, and create capital for re-deployment into new quality-growth holdings at inefficient valuations.

Arguably, in today’s more highly valued market and slow economy, finding high reward with low risk opportunities is a challenge. Nevertheless, the seasoning and creativity of Kalmar’s investment team, the benefits of purposefully casting a wide research net into areas not necessarily considered “growthy”, plus a longer term focus than employed by many investors assists this process. So does the discovery opportunity inherent in the several-thousand-stock small stock universe and the deep knowledge base, which we continually feed, of Kalmar’s 10-person investment team. Suffice to say that we have still been able to refresh the Fund portfolio with new opportunities that complement our longer term positions.

Economic and Market Outlook

Since fall 2012 Kalmar has been up-beat on U.S. equity market prospects, more so than many observers. In part this was because we have believed for an extended period that the U.S. is the best house on the world block. That conviction, coupled with our more positive views on the economic and market outlook for 2013, have been well rewarded despite substantial economic and policy uncertainties and political gridlock. We also remain several-year bullish, though there will be significant corrections along the way – possibly triggered by overvaluation or third world events, who knows – and inevitably greater market volatility than in 2013.

5

KALMAR

POOLED

INVESTMENT

TRUST

“GROWTH-WITH-VALUE”

SMALL CAP FUND

Report from Management — continued

Our view is pretty simple: Despite the internationally embarrassing dysfunction in Washington – and the more highly valued market – the U.S. Economy is gradually strengthening. Layoffs are dwindling, hiring and capital spending plans are rising, the wealth effect is now a positive, and housing has moved from a substantial drag to a cyclical driver. Europe has bottomed and green shoots are sprouting. Japan too, but somewhat more robustly so. China’s growth trajectory will be benefitted by all this – though its economy is in a definite slowing trend and a blow-up in its debt-fueled financial and shadow banking system probably represents the biggest risk to developed markets among the “known unknowns”. Even more so in case of such a dangerous event, concerted central bank stimulus likely would continue to support the global economy and “tapering” will be gradual both here and abroad. We appear some time away from monetary tightening. Moreover, with significant output gaps in many economies and a potential gathering of positives, we do not envisage recession risk for several years – rather a probable improvement in the rate of U.S. and world growth – which we believe can support market valuations on rising earnings.

This possibility suggests to us an on-going beneficial outlook for equities, continuation of a gradual secular shift from bonds to stocks, and potentially good 2014 returns as well when all is said and done. Kindly remember, though, that Kalmar manages the Fund holdings by holding bottom-up, seeking companies that can thrive against a range of economic outcomes and not against the dictates of any specific scenario. Also remember that for shareholders we seek to avoid swing-for-the-fences volatility in favor of longer term, strong risk-adjusted returns.

Organizational Developments

Things go very well at Kalmar. Morale and energy are high throughout. Our 10-person investment team, we believe, is the deepest and most capable in the firm’s history – and like our trading operations, admin/compliance, and client service teams – is stable, productive, and motivated to succeed for shareholders.

We wish you all a successful, healthy, and prosperous New Year. As discouraging as things often are in Washington, in the U.S. broadly as well as internationally the outlook is better. There appears to be a synchronized but gradual global expansion underway that could succeed in raising growth without boosting inflation significantly for some time. If this were to transpire, it should be a good combination for future equity returns.

Yours faithfully,

Ford B. Draper, Jr., President

Kalmar Pooled Investment Trust

6

KALMAR

POOLED

INVESTMENT

TRUST

“GROWTH-WITH-VALUE”

SMALL CAP FUND

Report from Management — continued

IMPORTANT INFORMATION

Kalmar’s comments reflect the investment adviser’s general opinions regarding the market, economy, and any stocks mentioned or stock opinions given, were current only as of the date of this letter, and are subject to change at any time. The information provided in this letter is not sufficient upon which to base an investment decision and should not be considered a recommendation to purchase or sell a particular security.

A preponderant portion of the investments in the Kalmar Fund are in small cap stocks. Investments in small cap stocks involve greater risks than investments in larger, more established companies, are more volatile, and may suffer significant losses. Further, the market for small cap stocks is generally less liquid than the markets for larger stocks, which can contribute to increased price volatility of small cap stocks. Kalmar invests in growth stocks with the potential for significant growth and may be more volatile because they are more sensitive to market conditions. Kalmar may seek to buy these stocks at undervalued prices and this involves the risk that the securities may remain undervalued for an extended period of time and may not realize its full potential. Market or economic conditions can vary widely over time and can result in a loss of portfolio value.

Current and future portfolio holdings are subject risk. There is no guarantee that the Kalmar Fund will continue to hold any one particular security or stay invested in any one particular sector. The performance of any single portfolio holding is no indication of the performance of other portfolio holdings or of the performance of the Fund itself. This commentary is not representative of all securities purchased or sold for the Kalmar Fund. Holdings are subject to change. Kalmar Investments will provide a list of security purchases and sales for the past 12 months upon request. The market cap values are shown at time of purchase.

ROE (Return on equity) measures a corporation’s profitability by revealing how much profit a company generates with the money shareholders have invested. Beta measures a portfolio’s sensitivity to market movements. The beta of the market is 1.00 by definition.

The Kalmar “Growth-with-Value” Small Cap Fund’s benchmark is the Russell 2000 ^® Growth. The Russell 2000 ^® Growth Index is reconstituted annually and measures the performance of those Russell 2000 companies with higher price-to-book ratios and higher forecasted growth rates. The Russell 2000 ^® Index covers up to 2,000 companies in the U.S. market. The Russell 2000 ^® Index and Russell 2000 Growth ^® Index are registered trademarks of Russell Investments. Russell is a trademark of Russell Investments. For comparative purposes, the S&P 500 index is shown. The S&P 500 Index is an unmanaged group of securities generally considered to represent the performance of the large capitalization sector of the U.S. equity securities market.

The indices mentioned here-in are unmanaged and not available for direct investment. Unlike a mutual fund, the performance of these indices assumes no taxes, transaction costs, management fees or other expenses.

Shares of the Kalmar Pooled Investment Trust are distributed by Foreside Funds Distributors LLC, Berwyn, PA., not an adviser affiliate.

7

KALMAR

POOLED

INVESTMENT

TRUST

“GROWTH-WITH-VALUE”

SMALL CAP FUND

Report from Management — concluded

Kalmar Pooled Investment Trust — “Growth-with-Value” Small Cap Fund — Investor Class Shares

Growth of $10,000 vs. The Russell 2000 ^® Growth Index and The Russell 2000 ^® Index

The performance data quoted represents past performance and does not guarantee future results. Current performance may be lower or higher. Performance data current to the most recent month-end may be obtained by calling 800-463-6670. The investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares. The Fund’s annual gross operating expense, as stated in the current prospectus, is 1.52%, 1.27% and 1.37% with respect to the Investor Class, the Institutional Class and the Advisor Class. This rate can fluctuate and may differ from the actual expenses incurred for the period covered by this report. The Fund’s investment adviser, Kalmar Investment Advisers (“Kalmar” or the “Adviser”), has contractually agreed to the reimbursement of other operating expenses or the waiver of all or a portion of its advisory fee in order to limit “Total Annual Fund Operating Expenses,” excluding extraordinary expenses, brokerage commissions, interest and “Acquired Fund Fees and Expenses,” to, as a percentage of average daily net assets, 1.50%, 1.25% and 1.35% with respect to the Investor Class, the Institutional Class and the Advisor Class, respectively (the “Expense Limitation”). Kalmar will reimburse expenses attributable to a specific class before waiving its advisory fee or reimbursing other expenses allocated to the Fund as a whole (“Fund-wide expenses”). The Expense Limitation will remain in place until April 30, 2014, unless the Board of Trustees approves its earlier termination. Subject to approval by the Board of Trustees, the Adviser may recoup any expenses reimbursed or fees waived within a three-year period from the year in which the Adviser reimbursed expenses of a Class or the Fund or waived its fees. No recoupment will occur unless the expenses of a Class or the Fund are below the Expense Limitation. The Fund imposes a 2% redemption fee calculated as a percentage of the amount redeemed and is charged only if shares are redeemed within 90 days of purchase.

The Russell 2000 ^® Growth and the Russell 2000 ^® indices are unmanaged stock market indices and do not reflect any asset-based charges for investment management or transaction expenses. It is not possible to invest directly into an index.

8

KALMAR

POOLED

INVESTMENT

TRUST

“GROWTH-WITH-VALUE”

SMALL CAP FUND

Fund Expense Example

(Unaudited)

As a shareholder of the Fund, you incur two types of costs: (1) transaction costs, including redemption fees, and (2) ongoing costs, including management fees and other Fund expenses. This example is intended to help you understand your ongoing costs (in dollars) of investing in the Fund and to compare these costs with the ongoing costs of investing in other mutual funds.

The example is based on an investment of $1,000 invested at the beginning of the period and held for the entire six months ended December 31, 2013.

Actual Expenses

The first line of the table below provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line under the heading entitled “Expenses Paid During Six Months Ended December 31, 2013” to estimate the expenses you paid on your account during this period.

Hypothetical Example for Comparison Purposes

The second line of the table below provides information about hypothetical account values and hypothetical expenses based on the Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund’s actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.

9

KALMAR

POOLED

INVESTMENT

TRUST

“GROWTH-WITH-VALUE”

SMALL CAP FUND

Fund Expense Example — concluded

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as redemption fees. Therefore, the second line of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if transactional costs were included, your costs would have been higher.

10

See Accompanying Notes to Financial Statements

11

See Accompanying Notes to Financial Statements

12

See Accompanying Notes to Financial Statements

13

See Accompanying Notes to Financial Statements

14

See Accompanying Notes to Financial Statements

15

See Accompanying Notes to Financial Statements

16

See Accompanying Notes to Financial Statements

17

ADR American Depository Receipt

See Accompanying Notes to Financial Statements

18